135 related articles for article (PubMed ID: 37516327)
1. A tumor-associated macrophages related model for predicting biochemical recurrence and tumor immune environment in prostate cancer.
Chen JY; Huang XY; Lin F; You Q; Xue YT; Lin B; Zheng QS; Wei Y; Xue XY; Li XD; Chen DN; Xu N
Genomics; 2023 Sep; 115(5):110691. PubMed ID: 37516327
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages and PD-L1 in prostate cancer: a possible key to unlocking immunotherapy efficacy.
Wang J; Wu W; Yuan T; Wang L; Zang L; Liu Q; Wang L; Huo X; Huo B; Tang Y; Wang H; Zhao Z
Aging (Albany NY); 2024 Jan; 16(1):445-465. PubMed ID: 38189834
[TBL] [Abstract][Full Text] [Related]
3. A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer.
Ke ZB; You Q; Sun JB; Zhu JM; Li XD; Chen DN; Su L; Zheng QS; Wei Y; Xue XY; Xu N
Front Cell Dev Biol; 2021; 9():774625. PubMed ID: 35071228
[No Abstract] [Full Text] [Related]
4. M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
JiaWei Z; ChunXia D; CunDong L; Yang L; JianKun Y; HaiFeng D; Cheng Y; ZhiPeng H; HongYi W; DeYing L; ZhiJian L; Xiao X; QiZhao Z; KangYi X; WenBing G; Ming X; JunHao Z; JiMing B; ShanChao Z; MingKun C
Ann Med; 2021 Dec; 53(1):730-740. PubMed ID: 34032524
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic Analysis of NSCLC Based on the Tumor-associated Macrophages, Tumor Neo-vessels and PD-L1 Expression in Tumor Microenvironment].
Hang Q; Ying H; Cheng G; Yang S; Jin J; Chen Y; Chen Q; Jiang Y; Zhao Q; Fang M; Chen M; Lai X
Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):837-844. PubMed ID: 33070512
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
[TBL] [Abstract][Full Text] [Related]
7. A Liquid-Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients.
You Q; Chen JY; Wu XH; Xue YT; Sun JB; Wei Y; Zheng QS; Xue XY; Chen DN; Xu N
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982591
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome-related prognostic index: Predicting biochemical recurrence and differentiating between cold and hot tumors in prostate cancer.
Ren C; Wang Q; Wang S; Zhou H; Xu M; Li H; Li Y; Chen X; Liu X
Front Endocrinol (Lausanne); 2023; 14():1148117. PubMed ID: 37033267
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.
Zhu W; Wu J; Huang J; Xiao D; Li F; Wu C; Li X; Zeng H; Zheng J; Lai W; Wen X
Front Immunol; 2023; 14():1122670. PubMed ID: 37122696
[TBL] [Abstract][Full Text] [Related]
10. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
11. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
Sun X; Wang C; Chen C; Huang J; Wu X; Wang Y; He X; Cao J; Jiang W; Sun P; Li Z
Hematol Oncol; 2021 Dec; 39(5):625-638. PubMed ID: 34543472
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
[No Abstract] [Full Text] [Related]
13. Poor clinical outcomes and immunoevasive contexture in SIRPα
Xu Z; Zeng H; Liu Z; Jin K; Chang Y; Wang Y; Liu L; Zhu Y; Xu L; Wang Z; Guo J; Xu J
Urol Oncol; 2022 Mar; 40(3):109.e11-109.e20. PubMed ID: 34600802
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC).
Li Y; Liu H; Zhao Y; Yue D; Chen C; Li C; Zhang Z; Wang C
Thorac Cancer; 2021 Oct; 12(20):2698-2709. PubMed ID: 34423566
[TBL] [Abstract][Full Text] [Related]
15. A radiation resistance related index for biochemical recurrence and tumor immune environment in prostate cancer patients.
Ke ZB; You Q; Chen JY; Sun JB; Xue YT; Zhuang RB; Zheng QS; Chen YH; Wei Y; Sun XL; Xue XY; Xu N
Comput Biol Med; 2022 Jul; 146():105711. PubMed ID: 35701253
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.
Zhao X; Qu J; Sun Y; Wang J; Liu X; Wang F; Zhang H; Wang W; Ma X; Gao X; Zhang S
Oncotarget; 2017 May; 8(18):30576-30586. PubMed ID: 28427165
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages related signature in glioma.
Wang LJ; Xue Y; Lou Y
Aging (Albany NY); 2022 Mar; 14(6):2720-2735. PubMed ID: 35332109
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
[TBL] [Abstract][Full Text] [Related]
19. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
[TBL] [Abstract][Full Text] [Related]
20. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer.
Masetti M; Carriero R; Portale F; Marelli G; Morina N; Pandini M; Iovino M; Partini B; Erreni M; Ponzetta A; Magrini E; Colombo P; Elefante G; Colombo FS; den Haan JMM; Peano C; Cibella J; Termanini A; Kunderfranco P; Brummelman J; Chung MWH; Lazzeri M; Hurle R; Casale P; Lugli E; DePinho RA; Mukhopadhyay S; Gordon S; Di Mitri D
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34919143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
